BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16390818)

  • 21. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans.
    Lennernäs H; Gjellan K; Hallgren R; Graffner C
    J Pharm Pharmacol; 2002 Apr; 54(4):499-508. PubMed ID: 11999127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of colonic drug absorption by the transcellular permeation route.
    Tomita M; Hayashi M; Horie T; Ishizawa T; Awazu S
    Pharm Res; 1988 Dec; 5(12):786-9. PubMed ID: 3247289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
    Brayden DJ; Walsh E
    AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons.
    Shimazaki T; Tomita M; Sadahiro S; Hayashi M; Awazu S
    Dig Dis Sci; 1998 Mar; 43(3):641-5. PubMed ID: 9539662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
    Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
    Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
    Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
    Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology.
    Chao AC; Nguyen JV; Broughall M; Griffin A; Fix JA; Daddona PE
    Int J Pharm; 1999 Nov; 191(1):15-24. PubMed ID: 10556736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of synergistic permeation enhancers for oral drug delivery.
    Whitehead K; Karr N; Mitragotri S
    J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B.
    Zhou L; Chow MS; Zuo Z
    Int J Pharm; 2009 Sep; 379(1):109-18. PubMed ID: 19555749
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Tran H; Aihara E; Mohammed FA; Qu H; Riley A; Su Y; Lai X; Huang S; Aburub A; Chen JJH; Vitale OH; Lao Y; Estwick S; Qi Z; ElSayed MEH
    Mol Pharm; 2023 Feb; 20(2):929-941. PubMed ID: 36592951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papain: an effective permeation enhancer for orally administered low molecular weight heparin.
    Grabovac V; Schmitz T; Föger F; Bernkop-Schnürch A
    Pharm Res; 2007 May; 24(5):1001-6. PubMed ID: 17372680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats.
    Mori S; Matsuura A; Rama Prasad YV; Takada K
    Biol Pharm Bull; 2004 Mar; 27(3):418-21. PubMed ID: 14993814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
    Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
    J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
    Gleeson JP; Frías JM; Ryan SM; Brayden DJ
    Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experiences and Translatability of
    Emeh P; Breitholtz K; Berg S; Vedin C; Englund M; Uggla T; Antonsson M; Nunes F; Hilgendorf C; Bergström CAS; Davies N
    Mol Pharm; 2024 Jan; 21(1):313-324. PubMed ID: 38054599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
    Fan D; Wu X; Dong W; Sun W; Li J; Tang X
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1447-56. PubMed ID: 23020091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral cavity delivery system of unfractionated and low molecular weight heparin].
    Li D; Hou HM
    Yao Xue Xue Bao; 2010 Oct; 45(10):1317-21. PubMed ID: 21348313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.